Hut 8 Corp to Ring Opening Bell at Nasdaq
MIAMI, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Hut 8 Corp. (Nasdaq | TSX: HUT), ("Hut 8” or the “Company”) one of North America’s...
Keros Therapeutics Announces Closing of Upsized Public
LEXINGTON, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or “we”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
eFFECTOR Therapeutics Announces Reverse Stock Split
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the...
OPKO Health Announces Closing of Private Offering of $230
MIAMI, Jan. 09, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the closing of its previously announced...
Waldencast plc Announces Receipt of Anticipated Nasdaq
NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness...
Peter Deeb/ Deeb & Company Limited Advises of Sale of
TORONTO, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Pursuant to the requirements of National Instrument 62-103 ― The Early Warning System and Related Take Over...
Elutia Regains Compliance with Nasdaq Listing Requirements
SILVER SPRING, Md., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) today announced that it has regained compliance with Nasdaq’s...
Bioventus Announces Inducement Equity to President and
DURHAM, N.C., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for...
FINSIGHT Group Inc. Calls on Q4 Inc. Shareholders to Vote
The proxy materials reveal a flawed process initiated and managed by a conflicted board, conflicted management, and conflicted insiders. Non-Rolling Shareholders, who collectively...
Nasdaq Announces End of Month Open Short Interest Positions
NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of December 29, 2023, short interest in...
Oportun Reports Inducement Grants under Nasdaq Listing Rule
SAN CARLOS, Calif., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Oportun (Nasdaq: OPRT), a mission-driven fintech, today announced that on September 10, 2023, it...
TransCode Therapeutics Announces 1-for-40 Reverse Stock
BOSTON, Jan. 11, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (“TransCode” or the “Company”), the RNA Oncology Company™ committed to...
